Literature DB >> 21989663

Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties.

Aurélie Tchoghandjian1, Nathalie Baeza-Kallee, Christophe Beclin, Philippe Metellus, Carole Colin, François Ducray, José Adélaïde, Geneviève Rougon, Dominique Figarella-Branger.   

Abstract

BACKGROUND: Cellular self-renewal capacity in glioblastomas is heterogeneous, with only stem-like cells having this property. These cells generate a specific tumor phenotype, but no link with tumor location or molecular characteristics has ever been made.
METHODS: Two cells lines, established from cell-dissociated glioblastomas and A2B5+ magnetic cell sorting, were used to decipher the mechanisms of cell migration in glioblastomas. GBM6 was derived from a glioblastoma close to the subventricular zone, whereas GBM9 was derived from a cortical glioblastoma and contained a high number of CD133(+) cells.
RESULTS: Orthotopic injections in both the subventricular zone and the cortex of nude mice showed that GBM6 and GBM9 cells had a differential pattern of migration that mirrored that of adult and fetal normal neural stem cells, respectively. GBM6 demonstrated higher tumorigenicity than GBM9, and whichever cell line was injected, subventricular zone-implanted tumors were larger than cortical ones. In vitro, GBM6 and GBM9 displayed high autorenewal and proliferation rates, and their expression profiles and genomic status showed that they had distinctive molecular signatures: GBM6 was classified as a mesenchymal glioblastoma and GBM9 as a proneural glioblastoma.
CONCLUSIONS: Altogether, our findings suggest that tumor location in addition to molecular signature influence tumor growth and migration pattern.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21989663     DOI: 10.1245/s10434-011-2093-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  17 in total

Review 1.  Stem cell niche irradiation in glioblastoma: providing a ray of hope?

Authors:  Tejpal Gupta; Vimoj Nair; Rakesh Jalali
Journal:  CNS Oncol       Date:  2014

2.  Chemotactic responses of neural stem cells to SDF-1α correlate closely with their differentiation status.

Authors:  Yebing Chen; Youhua Wei; Jing Liu; Huanxiang Zhang
Journal:  J Mol Neurosci       Date:  2014-03-22       Impact factor: 3.444

3.  Long non-coding RNA Fer-1-like family member 4 is overexpressed in human glioblastoma and regulates the tumorigenicity of glioma cells.

Authors:  Feng Ding; Hongtu Tang; Dekang Nie; Liang Xia
Journal:  Oncol Lett       Date:  2017-06-16       Impact factor: 2.967

Review 4.  Glioblastoma treatment using perphenazine to block the subventricular zone's tumor trophic functions.

Authors:  R E Kast; B M Ellingson; C Marosi; M-E Halatsch
Journal:  J Neurooncol       Date:  2013-11-17       Impact factor: 4.130

5.  Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish.

Authors:  Chuan Yan; Dalton C Brunson; Qin Tang; Daniel Do; Nicolae A Iftimia; John C Moore; Madeline N Hayes; Alessandra M Welker; Elaine G Garcia; Taronish D Dubash; Xin Hong; Benjamin J Drapkin; David T Myers; Sarah Phat; Angela Volorio; Dieuwke L Marvin; Matteo Ligorio; Lyle Dershowitz; Karin M McCarthy; Murat N Karabacak; Jonathan A Fletcher; Dennis C Sgroi; John A Iafrate; Shyamala Maheswaran; Nick J Dyson; Daniel A Haber; John F Rawls; David M Langenau
Journal:  Cell       Date:  2019-04-25       Impact factor: 41.582

6.  End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo.

Authors:  Raphael Berges; Nathalie Baeza-Kallee; Emeline Tabouret; Olivier Chinot; Marie Petit; Anna Kruczynski; Dominique Figarella-Branger; Stephane Honore; Diane Braguer
Journal:  Oncotarget       Date:  2014-12-30

7.  Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo.

Authors:  Emilie Denicolaï; Nathalie Baeza-Kallee; Aurélie Tchoghandjian; Manon Carré; Carole Colin; Carine Jiguet Jiglaire; Sandy Mercurio; Christophe Beclin; Dominique Figarella-Branger
Journal:  Oncotarget       Date:  2014-11-15

8.  Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152.

Authors:  A Tchoghandjian; A Soubéran; E Tabouret; C Colin; E Denicolaï; C Jiguet-Jiglaire; A El-Battari; C Villard; N Baeza-Kallee; D Figarella-Branger
Journal:  Cell Death Dis       Date:  2016-08-04       Impact factor: 8.469

9.  Identification of a novel set of genes reflecting different in vivo invasive patterns of human GBM cells.

Authors:  Massimiliano Monticone; Antonio Daga; Simona Candiani; Francesco Romeo; Valentina Mirisola; Silvia Viaggi; Ilaria Melloni; Simona Pedemonte; Gianluigi Zona; Walter Giaretti; Ulrich Pfeffer; Patrizio Castagnola
Journal:  BMC Cancer       Date:  2012-08-17       Impact factor: 4.430

10.  Molecular heterogeneity of glioblastomas: does location matter?

Authors:  Emilie Denicolaï; Emeline Tabouret; Carole Colin; Philippe Metellus; Isabelle Nanni; Celine Boucard; Aurélie Tchoghandjian; David Meyronet; Nathalie Baeza-Kallee; Olivier Chinot; Dominique Figarella-Branger
Journal:  Oncotarget       Date:  2016-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.